[Alternative therapy of benign prostatic hypertrophy--Permixon (Capistan)].
In a multicentre study in four urological departments in the Czech Republic the authors evaluated, based on an elaborated protocol, the effect of the preparation Permixon in patients with complaints associated with benign hyperplasia of the prostate (BPH). They followed-up changes of Goldenberg's symptom score and quantitative indicators of urinary flow, postmicturition residues, the prostate volume and other parameters of the urodynamic examination. Statistical evaluation of the results provided evidence of the effectiveness of the preparation which is considered suitable by the authors, in particular in incipient complaints when the patient complains of discomfort during miction and thus of an altered quality of life.
Hanus
M
M
Urologická klinika 1. lékarské faculty Univerzity Karlovy, Praha.
Matousková
M
M
D000368:Aged; D000369:Aged, 80 and over; D000726:Androgen Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010936:Plant Extracts / Q000627:therapeutic use*; D011470:Prostatic Hyperplasia / Q000188:drug therapy*; D028024:Serenoa
D000726:Androgen Antagonists; D010936:Plant Extracts; C040972:saw palmetto extract